Nano Dimension

NNDM

Market cap $312M

WALTHAM, Mass.--(BUSINESS WIRE)--Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano,” or the “Company”) today issued the following letter to shareholders regarding its upcoming Extraordinary General Meeting (“EGM”) scheduled for July 31, 2026. Nano's Board of Directors (the “Board”) urges shareholders to carefully evaluate its recommendations and vote accordingly. Dear Fellow Shareholders: The upcoming Extraordinary General Meeting centers on a fundamental question: should Murchinson L.

Companies Provide Additional Color on Infinite's Business Model, Market Opportunity and Capital Plan, and Respond to Murchinson Ltd.'s Letter Companies Provide Additional Color on Infinite's Business Model, Market Opportunity and Capital Plan, and Respond to Murchinson Ltd.'s Letter

TORONTO--(BUSINESS WIRE)--Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, "Murchinson" or "we"), a significant shareholder with approximately 7.4% of the outstanding shares of Nano Dimension Ltd. (NASDAQ: NNDM) ("Nano" or the "Company"), today commented on Nano's announcement that it has signed a non-binding term sheet with Infinite Epigenetics (“Infinite” or “Infinite Epigenetics”) to form a publicly traded, AI-powered health and diagnostics company.1.

Nano Dimension Ltd. (NNDM) M&A Call Prepared Remarks Transcript

WALTHAM, Mass., June 15, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano”) today announced it has entered into a non-binding term sheet for a proposed business combination (“combination”) with Infinite Epigenetics ™ (“Infinite Epigenetics,” “Infinite”), an artificial intelligence (“AI”)-powered preventive health and diagnostics company building a proprietary biological AI platform to read, interpret, and apply epigenetic signals at scale.

TORONTO--(BUSINESS WIRE)--Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, “Murchinson” or “we”), a significant shareholder with approximately 7.4% of the outstanding shares of Nano Dimension Ltd. (NASDAQ: NNDM) (“Nano” or the “Company”), today issued the following letter to Nano shareholders. *** Fellow Nano Shareholders, Over the last few weeks and months, we have heard CEO Dave Stehlin repeatedly say that Nano's Board of Directors (the “Board”), led.

Company Continues to Move Forward on Three-Phase Strategic Plan to Maximize Long-Term Shareholder Value Company Continues to Move Forward on Three-Phase Strategic Plan to Maximize Long-Term Shareholder Value

Accelerating Progress Toward Unlocking and Maximizing Long-Term Shareholder Value Transaction Expected to Reduce Annualized Cash Burn by Approximately $15 Million WALTHAM, Mass., May 27, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd.

TORONTO--(BUSINESS WIRE)--Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, “Murchinson” or “we”), a significant shareholder with approximately 7.4% of the outstanding shares of Nano Dimension Ltd. (NASDAQ: NNDM) (“Nano” or the “Company”), today announced it will host an investor conference call to discuss the Company's so-called strategic review, Chairman Bob Pons' role in the “review process,” and other concerns related to the Company's business and co.

Comments on Amended Schedule 13D Filing by Murchinson Strategic Alternatives Review Process Progresses WALTHAM, Mass., May 26, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd.